• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高水平的肠道归巢免疫球蛋白 A+B 淋巴细胞支持肠道黏膜高反应性在免疫球蛋白 A 肾病患者中的致病作用。

High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients.

机构信息

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", Bari, Italy.

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari "Aldo Moro", Bari, Italy.

出版信息

Nephrol Dial Transplant. 2021 Feb 20;36(3):452-464. doi: 10.1093/ndt/gfaa264.

DOI:10.1093/ndt/gfaa264
PMID:33200215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7898021/
Abstract

BACKGROUND

Immunoglobulin A nephropathy (IgAN) is the most frequent primary glomerulonephritis. The role of the microbiota and mucosal immunity in the pathogenesis of IgAN remains a key element. To date, the hypothetical relationship between commensal bacteria, elevated tumour necrosis factor (TNF) superfamily member 13 [also known as B-cell activating factor (BAFF)] levels, perturbed homoeostasis of intestinal-activated B cells and intestinal IgA class switch has not been clearly shown in IgAN patients.

METHODS

We studied the intestinal-renal axis connections, analysing levels of BAFF, TNF ligand superfamily member 13 (APRIL) and intestinal-activated B cells in IgAN patients, healthy subjects (HSs) and patients with non-IgA glomerulonephritides.

RESULTS

IgAN patients had increased serum levels of BAFF cytokine, correlating with higher amounts of five specific microbiota metabolites, and high APRIL cytokine serum levels. We also found that subjects with IgAN have a higher level of circulating gut-homing (CCR9+ β7 integrin+) regultory B cells, memory B cells and IgA+ memory B cells compared with HSs. Finally, we found that IgAN patients had high levels of both total plasmablasts (PBs) and intestinal-homing PBs. Interestingly, PBs significantly increased in IgAN but not in patients with other glomerulonephritides.

CONCLUSIONS

Our results demonstrate a significant difference in the amount of intestinal-activated B lymphocytes between IgAN patients and HSs, confirming the hypothesis of the pathogenic role of intestinal mucosal hyperresponsiveness in IgAN. The intestinal-renal axis plays a crucial role in IgAN and several factors may contribute to its complex pathogenesis and provide an important area of research for novel targeted therapies to modulate progression of the disease.

摘要

背景

免疫球蛋白 A 肾病(IgAN)是最常见的原发性肾小球肾炎。微生物群和黏膜免疫在 IgAN 发病机制中的作用仍然是一个关键因素。迄今为止,共生细菌、肿瘤坏死因子(TNF)超家族成员 13[也称为 B 细胞激活因子(BAFF)]水平升高、肠道激活 B 细胞的内稳态紊乱以及肠道 IgA 类转换之间的假设关系尚未在 IgAN 患者中得到明确证明。

方法

我们研究了肠-肾轴的联系,分析了 IgAN 患者、健康受试者(HS)和非 IgA 肾小球肾炎患者的 BAFF、TNF 配体超家族成员 13(APRIL)和肠道激活 B 细胞的水平。

结果

IgAN 患者的 BAFF 细胞因子血清水平升高,与五种特定微生物群代谢物的含量增加以及 APRIL 细胞因子血清水平升高相关。我们还发现,与 HS 相比,IgAN 患者具有更高水平的循环肠道归巢(CCR9+β7 整合素+)调节性 B 细胞、记忆 B 细胞和 IgA+记忆 B 细胞。最后,我们发现 IgAN 患者的总浆母细胞(PBs)和肠道归巢 PBs 水平均较高。有趣的是,IgAN 患者的 PBs 显著增加,但在其他肾小球肾炎患者中则没有增加。

结论

我们的研究结果表明 IgAN 患者与 HS 之间肠道激活 B 淋巴细胞的数量存在显著差异,证实了肠道黏膜高反应性在 IgAN 发病机制中的致病作用假说。肠-肾轴在 IgAN 中起着至关重要的作用,并且有几个因素可能导致其复杂的发病机制,为调节疾病进展的新型靶向治疗提供了一个重要的研究领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/391351c765b3/gfaa264f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/2bef7e08fa17/gfaa264f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/1dbee61974cf/gfaa264f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/6f98b3d091f5/gfaa264f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/091ec62867e3/gfaa264f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/4de7dded2305/gfaa264f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/93501d9c535c/gfaa264f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/4191835a1e93/gfaa264f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/391351c765b3/gfaa264f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/2bef7e08fa17/gfaa264f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/1dbee61974cf/gfaa264f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/6f98b3d091f5/gfaa264f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/091ec62867e3/gfaa264f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/4de7dded2305/gfaa264f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/93501d9c535c/gfaa264f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/4191835a1e93/gfaa264f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97cf/7898021/391351c765b3/gfaa264f7.jpg

相似文献

1
High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients.高水平的肠道归巢免疫球蛋白 A+B 淋巴细胞支持肠道黏膜高反应性在免疫球蛋白 A 肾病患者中的致病作用。
Nephrol Dial Transplant. 2021 Feb 20;36(3):452-464. doi: 10.1093/ndt/gfaa264.
2
The Gut-Renal Connection in IgA Nephropathy.IgA 肾病中的肠-肾关联。
Semin Nephrol. 2018 Sep;38(5):504-512. doi: 10.1016/j.semnephrol.2018.05.020.
3
Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.黏膜免疫反应、感染和肠道微生物组如何影响 IgA 肾病和未来的治疗方法。
Theranostics. 2020 Sep 15;10(25):11462-11478. doi: 10.7150/thno.49778. eCollection 2020.
4
Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy.免疫球蛋白 A 肾病中扁桃体微生物群的异常黏膜免疫反应。
Nephrol Dial Transplant. 2021 Jan 1;36(1):75-86. doi: 10.1093/ndt/gfaa223.
5
Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population.肠道微生物群的改变与中国人群 IgA 肾病的严重程度相关。
Int Immunopharmacol. 2020 Dec;89(Pt B):107085. doi: 10.1016/j.intimp.2020.107085. Epub 2020 Oct 14.
6
Aberrant Gut Microbiome Contributes to Barrier Dysfunction, Inflammation, and Local Immune Responses in IgA Nephropathy.肠道微生物组异常导致 IgA 肾病的屏障功能障碍、炎症和局部免疫反应。
Kidney Blood Press Res. 2023;48(1):261-276. doi: 10.1159/000528973. Epub 2023 Mar 6.
7
Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A Nephropathy.肠道微生物群在免疫球蛋白 A 肾病中的发病机制和治疗作用。
Curr Pharm Des. 2023;29(6):468-473. doi: 10.2174/1381612829666230224092657.
8
The microbiome and IgA nephropathy.微生物组与 IgA 肾病。
Semin Immunopathol. 2021 Oct;43(5):649-656. doi: 10.1007/s00281-021-00893-6. Epub 2021 Oct 18.
9
Thymic stromal lymphopoietin in tonsillar follicular dendritic cells correlates with elevated serum immunoglobulin A titer by promoting tonsillar immunoglobulin A class switching in immunoglobulin A nephropathy.扁桃体滤泡树突状细胞中的胸腺基质淋巴细胞生成素通过促进IgA肾病中扁桃体免疫球蛋白A类别转换,与血清免疫球蛋白A滴度升高相关。
Transl Res. 2016 Oct;176:1-17. doi: 10.1016/j.trsl.2016.04.008. Epub 2016 Apr 30.
10
Synthetic Double-Stranded RNA Poly(I:C) Aggravates IgA Nephropathy by Triggering IgA Class Switching Recombination through the TLR3-BAFF Axis.合成双链RNA聚肌苷酸胞嘧啶核苷(Poly(I:C))通过TLR3-BAFF轴触发IgA类别转换重组加重IgA肾病。
Am J Nephrol. 2015;42(3):185-97. doi: 10.1159/000440819. Epub 2015 Sep 30.

引用本文的文献

1
Exploring the role of APRIL in autoimmunity: implications for therapeutic targeting in systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome.探索增殖诱导配体(APRIL)在自身免疫中的作用:对系统性红斑狼疮、类风湿关节炎和干燥综合征治疗靶点的启示
Front Immunol. 2025 Aug 1;16:1523392. doi: 10.3389/fimmu.2025.1523392. eCollection 2025.
2
Opportunities and challenges in the treatment of IgA nephropathy.IgA肾病治疗中的机遇与挑战。
Front Pharmacol. 2025 Jul 30;16:1559593. doi: 10.3389/fphar.2025.1559593. eCollection 2025.
3
Immune Cell Characteristics in a Gut-Kidney Axis-Induced Mouse Model of IgA Nephropathy: The Upregulated Dendritic Cells and Neutrophils.

本文引用的文献

1
IgA and the intestinal microbiota: the importance of being specific.IgA 与肠道微生物群:具体问题具体分析的重要性。
Mucosal Immunol. 2020 Jan;13(1):12-21. doi: 10.1038/s41385-019-0227-4. Epub 2019 Nov 18.
2
Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice.口服抗生素调节肠道菌群可治疗人源化小鼠的免疫球蛋白 A 肾病。
Nephrol Dial Transplant. 2019 Jul 1;34(7):1135-1144. doi: 10.1093/ndt/gfy323.
3
The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition.
肠道-肾脏轴诱导的IgA肾病小鼠模型中的免疫细胞特征:树突状细胞和中性粒细胞上调
J Inflamm Res. 2025 Jul 1;18:8579-8592. doi: 10.2147/JIR.S519521. eCollection 2025.
4
APRIL: spring forward also for IgA vasculitis nephritis in children.四月:儿童免疫球蛋白A血管炎相关性肾炎也进入高发期。
Pediatr Nephrol. 2025 Jun 11. doi: 10.1007/s00467-025-06839-6.
5
Gut Microbiota and Immunoglobulin A Nephropathy: Exploration of Dietary Intervention and Treatment Strategies.肠道微生物群与免疫球蛋白A肾病:饮食干预及治疗策略探索
Food Sci Nutr. 2025 May 1;13(5):e70218. doi: 10.1002/fsn3.70218. eCollection 2025 May.
6
Emerging Biochemical and Immunologic Mechanisms in the Pathogenesis of IgA Nephropathy.IgA肾病发病机制中的新兴生化和免疫机制
Semin Nephrol. 2024 Sep;44(5):151565. doi: 10.1016/j.semnephrol.2025.151565. Epub 2025 Mar 13.
7
Single-Cell RNA-Sequencing Analysis Provides Insights into IgA Nephropathy.单细胞RNA测序分析为IgA肾病提供了见解。
Biomolecules. 2025 Jan 29;15(2):191. doi: 10.3390/biom15020191.
8
Characteristics, pathogenic and therapeutic role of gut microbiota in immunoglobulin A nephropathy.肠道微生物群在免疫球蛋白A肾病中的特征、致病作用及治疗作用
Front Immunol. 2025 Feb 6;16:1438683. doi: 10.3389/fimmu.2025.1438683. eCollection 2025.
9
Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression.肠道屏障和黏膜免疫相关微生物群的靶向调节可减轻IgA肾病进展。
Gut Microbes. 2025 Dec;17(1):2458184. doi: 10.1080/19490976.2025.2458184. Epub 2025 Jan 28.
10
The beneficial effect of adding belimumab in severe and refractory IgA nephropathy: a case report.在重症难治性IgA肾病中添加贝利尤单抗的有益效果:一例病例报告
Pediatr Nephrol. 2025 Jun;40(6):1903-1905. doi: 10.1007/s00467-024-06620-1. Epub 2025 Jan 8.
IgA 肾病的肠-肾轴:微生物组和饮食对遗传易感性的作用。
Pediatr Nephrol. 2018 Jan;33(1):53-61. doi: 10.1007/s00467-017-3652-1. Epub 2017 Apr 7.
4
Memory B Cells of Mice and Humans.小鼠和人类的记忆 B 细胞。
Annu Rev Immunol. 2017 Apr 26;35:255-284. doi: 10.1146/annurev-immunol-041015-055531. Epub 2017 Jan 30.
5
The mucosa-kidney axis in IgA nephropathy.IgA 肾病中的黏膜-肾脏轴。
Nat Rev Nephrol. 2016 Mar;12(3):147-56. doi: 10.1038/nrneph.2015.208. Epub 2015 Dec 30.
6
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.在一项回顾性国际研究中,发现循环中的miR-148b和let-7b是检测原发性IgA肾病的血清标志物。
Kidney Int. 2016 Mar;89(3):683-92. doi: 10.1038/ki.2015.333.
7
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.IgA肾病的遗传学、发病机制及治疗方面的新进展。
Kidney Int. 2015 Nov;88(5):974-89. doi: 10.1038/ki.2015.252. Epub 2015 Sep 16.
8
BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R.B淋巴细胞刺激因子(BAFF)通过与BAFF受体(BAFF-R)相互作用促进人系膜细胞增殖。
BMC Nephrol. 2015 May 15;16:72. doi: 10.1186/s12882-015-0064-y.
9
Regulatory B cells: origin, phenotype, and function.调节性 B 细胞:起源、表型和功能。
Immunity. 2015 Apr 21;42(4):607-12. doi: 10.1016/j.immuni.2015.04.005.
10
Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.麦胶蛋白通过麦胶蛋白-CD89 相互作用加重人源化小鼠的 IgA 肾病。
Kidney Int. 2015 Aug;88(2):276-85. doi: 10.1038/ki.2015.94. Epub 2015 Mar 25.